Research Groups and R&D Platforms: Target discovery
Research Group:
Cell fate – from molecular understanding to control
Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi
Turku Bioscience Centre and
Faculty of Science and Engineering,
Åbo Aakdemi University
Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery
Research Group:
Molecular imaging of atherosclerosis and heart failure
Antti Saraste
antti.saraste[at]utu.fi
Heart Center and PET Center,
University of Turku
Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging
Research Group:
Synthetic Glycocluster Adjuvants
Johannes Savolainen
johsav[at]utu.fi
Department of Clinical Medicine,
University of Turku
Allergy, Asthma, Biomedicine, Biomolecular chemistry, Biotechnology, Cancer, Immunology, Inflammation, Melanoma, Natural Compounds, NMR, Organic Chemistry, Synthetic Biology, Synthetic chemistry, Target discovery
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Radiochemistry for development of radiotracers for Positron Emission Tomography
Olof Solin
olof.solin[at]abo.fi, olof.solin[at]utu.fi
Turku PET Centre and Department of Chemistry,
University of Turku
Ageing-related diseases, Autoimmune diseases, Biomarker, Cancer, Data mining, Diabetes, Disease models, Drug delivery, Drug stability, Drug target, Formulation, Imaging, Imaging software, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular diagnostics, Molecular modelling, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Obesity, Organic compounds, Particle size analysis, PET, Physico-chemical properties, Receptor, Signaling, Synthetic chemistry, Target discovery, Zeta potential
Research Group:
Molecular determinants of picornaviral disease
Petri Susi
pesusi[at]utu.fi
Institute of Biomedicine,
University of Turku
Asthma, Basic research, Bioinformatics, Biomarker, Biotechnology, Cancer, Electron microscopy, Epidemiology, Genomics, Imaging, Imaging software, In Vitro Diagnostics, Infection, Molecular Biology, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Point of care, Target discovery, Virology
